The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Pancreatic carcinoma 7
SANDOSTATIN LAR DEPOT Pericardial effusion 7
SANDOSTATIN LAR DEPOT Polyp 7
SANDOSTATIN LAR DEPOT Pruritus generalised 7
SANDOSTATIN LAR DEPOT Rash pustular 7
SANDOSTATIN LAR DEPOT Renal cancer 7
SANDOSTATIN LAR DEPOT Renal neoplasm 7
SANDOSTATIN LAR DEPOT Shoulder deformity 7
SANDOSTATIN LAR DEPOT Stomatitis 7
SANDOSTATIN LAR DEPOT Thyroid neoplasm 7
SANDOSTATIN LAR DEPOT Toothache 7
SANDOSTATIN LAR DEPOT Unresponsive to stimuli 7
SANDOSTATIN LAR DEPOT Upper limb fracture 7
SANDOSTATIN LAR DEPOT Uterine neoplasm 7
SANDOSTATIN LAR DEPOT Vulvovaginal mycotic infection 7
SANDOSTATIN LAR DEPOT Weight gain poor 7
SANDOSTATIN Blood creatinine increased 6
SANDOSTATIN Blood iron decreased 6
SANDOSTATIN Blood magnesium decreased 6
SANDOSTATIN Body temperature increased 6

Total Records: 2,045     Number of Pages: 103